S. 41, Medicare Prescription Drug Price Negotiation Act of 2017, to allow Medicare to negotiate the best possible price of prescription drugs. Introduced Jan. 5.
S.771, Improving Access to Affordable Prescription Drugs Act of 2017, seeks to tackle prescription drug costs by increasing transparency and accountability, boosting access, preventing pay-for-delay deals to keep generics off the market, more affordability of key drugs, spurring innovation, and increase choice and competition, including allowing Medicare to negotiate lower prices. Introduced March 29.
The NRLN does not understand why you have not brought these bills up for a vote.